President and Founder, International Center for Law & Economics
Geoffrey A. Manne is the president and founder of the International Center for Law and Economics (ICLE), a nonprofit, nonpartisan research center based in Portland, Oregon. He is also a distinguished fellow at Northwestern Law School’s Searle Center on Law, Regulation, & Economic Growth. In April 2017 he was appointed by FCC Chairman Ajit Pai to the FCC’s Broadband Deployment Advisory Committee, and he recently served for two years on the FCC’s Consumer Advisory Committee.
Mr. Manne earned his JD and AB degrees from the University of Chicago and is an expert in the economic analysis of law, specializing in competition, telecommunications, consumer protection, intellectual property, and technology policy.
Prior to founding ICLE, Manne was a law professor at Lewis & Clark Law School. From 2006-2009, he took a leave from teaching to develop Microsoft’s law and economics academic outreach program. Manne has also served as a lecturer in law at the University of Chicago Law School and the University of Virginia School of Law. He practiced antitrust law and appellate litigation at Latham & Watkins, clerked for Hon. Morris S. Arnold on the 8th Circuit Court of Appeals, and worked as a research assistant for Judge Richard Posner. He was also once (very briefly) employed by the FTC.
Mr. Manne’s publications have appeared in numerous journals including the Journal of Competition Law and Economics, the Harvard Journal of Law and Technology, the Supreme Court Economic Review, and the Arizona Law Review, among others. With former FTC Commissioner, Joshua Wright, Manne is the editor of a volume from Cambridge University Press entitled, Competition Policy and Intellectual Property Law Under Uncertainty: Regulating Innovation. Manne has also testified on several occasions before Congress and at the FCC and FTC, and he regularly files written comments and amicus briefs on key antitrust, IP, and telecommunications issues. His analysis is frequently published in popular print and broadcasting outlets such as the Wall Street Journal, Wired, Foreign Affairs, NPR, and Bloomberg, among others.
Manne is a member of the American Law and Economics Association, the Canadian Law and Economics Association, and the Society for Institutional & Organizational Economics. He blogs at Truth on the Market (www.truthonthemarket.com) (of which he is also the co-founder), is a contributor at WIRED, and tweets at @geoffmanne. His scholarly publications are available at http://ssrn.com/author=175541.
Director of Innovation Policy, International Center for Law & Economics
Kristian Stout, ICLE’s Director of Innovation Policy is an expert in intellectual property, antitrust, telecommunications, and Internet governance. Kristian has been a Fellow at the Internet Law & Policy Foundry, as well as the Eagleton Institute of Politics. Before practicing law, Kristian worked as a technology entrepreneur and a lecturer in the Computer Science Department at Rutgers University. Kristian served on the board of the New Jersey Leadership Program, and wasthe Chair of the Asset Forfeiture Working Group for the NJ State Advisory Committee to the United States Commission on Civil Rights. He has previously served on the Broadband Deployment Advisory Committee for the Federal Communications Commission. Kristian graduated magna cum laude from the Rutgers University School of law, and served on the editorial board of the Rutgers Journal of Law and Public Policy.
Senior Scholar, International Center for Law & Economics
Julian Morris is a Senior Scholar at the International Center for Law & Economics.
Senior Fellow for Law & Economics, International Center for Law & Economics
Dirk Auer is the Senior Fellow for Law & Economics at the International Center for Law & Economics.
Director, Technology Licensing Office & Director, Catalysts, Office of Strategic Alliances & Technology Transfer, MIT
Lesley is formerly the director of the Office of Technology Management at the University of Illinois at Urbana-Champaign (UIUC), where she had responsibility for the oversight of all technology transfer activities across the university. In this position, Lesley demonstrated leadership in all phases of the commercialization of technology and intellectual property, ranging from proof of concept programs to enable the launch of startup companies through patenting and licensing processes. She played a major role in developing a thriving innovation ecosystem at UIUC, marked by strong corporate engagement. Beyond her university focus, Lesley has been a prominent speaker nationally and internationally on the economic importance of technology transfer.
Lesley holds bachelor’s and master’s degrees in education from the University of Edinburgh and the University of Georgia, respectively, and an MBA from UIUC.
Professor of Law, Antonin Scalia Law School, George Mason University
Adam Mossoff is Professor of Law at Antonin Scalia Law School, George Mason University. He has published extensively on why patents, copyrights, and other intellectual property rights have been—and should be—legally secured to innovators and creators as property rights. His scholarship has been relied on by the United States Supreme Court, by lower federal courts, and by U.S. federal agencies. He has been invited to testify numerous times before the U.S. Senate and the House of Representatives on intellectual property legislation. His writings on intellectual property policy have also appeared in the Wall Street Journal, New York Times, Forbes, Investors Business Daily, and in other media outlets. His journal articles can be downloaded here.
Professor Mossoff is a longstanding member of the Executive Committee of the Intellectual Property Practice Group of the Federalist Society, on which he served as Chairperson from 2016-2018, and he is Chair of the Intellectual Property Working Group of the Regulatory Transparency Project of the Federalist Society. He is a Senior Fellow and Chair of the Forum for Intellectual Property at the Hudson Institute, a Visiting Intellectual Property Fellow at the Heritage Foundation, and a member of the Board of Directors of the Center for Intellectual Property Understanding. He is a member of the Intellectual Property Rights Policy Committee of ANSI and he has served as Chair and Vice-Chair of the Intellectual Property Committee of the IEEE-USA, on which he remains a member in good standing.
Dinsmore & Shohl LLP, Partner
Brian is chair of Dinsmore’s IP Transactions and Licensing Group. He is a past president of the Licensing Executives Society (USA and Canada), Inc. (LES), the leading professional society devoted to commercial transactions and licensing of intangible property. He continues to serve LES as senior vice president for public policy. He has extensive experience in a wide variety of commercial transactions involving intangible property, and is known for creative licensing strategies to promote collaboration and resolve IP-related disputes.
He is a registered patent attorney with more than 30 years of experience before the U.S. Patent and Trademark Office and in structuring global IP portfolios and strategies. He has extensive experience in contested proceedings before the USPTO Patent Trial and Appeal Board (interferences, Inter Partes Reviews and Post Grant Reviews), as well as contested matters in federal courts and the International Trade Commission. His wide-ranging experience affords a broad, informed perspective and facilitates creative approaches to intellectual property management, licensing, and enforcement.
In addition to his leadership of LES, Brian served on the LES Board of Directors 2007 – 2018. In his ongoing role as senior vice president for public policy he is responsible for coordinating the society’s public policy positions, amicus briefs, and congressional outreach. He works with legislators, the executive branch, and the courts toward consistent, reliable, and prudent IP laws and policies that advance innovation and economic development. He has also served LES as trustee for education, and has long served as an author, editor, and faculty member of LES educational programs focusing on best practices in IP licensing.
He is also active in the global society, LES International (LESI). Among his various roles in LESI, he has served as co-chair of the External Relations Committee, coordinating public policy and advocacy for effective IP laws and policies among the 33 regional LES societies, and with various non-governmental organizations such as WIPO and EPO. In 2019, he received the LES International President’s Service Recognition Award.
Brian also serves as Chair of the Board of Directors of the Bayh Dole Coalition, a 501(c)(4) corporation dedicated to promoting and preserving the Bayh Dole Act. He is a member of the Founding Board of Directors of the United States Intellectual Property Alliance (USIPA), an organization dedicated to raising public awareness of, and appreciation for, the role of IP in fostering innovation for the public good; and he has served on the DC Bar Intellectual Property Section Steering Committee (2013 – 2016).
In 2016, Brian testified before the U.S. Senate Committee on Small Business and Entrepreneurship on the effects of the America Invents Act on small business and entrepreneurs in a hearing entitled “An Examination of Changes to the U.S. Patent System & Impacts on America's Small Businesses.”
With his longstanding and diverse patent practice, in both private practice and in-house, Brian advises corporate leaders and entrepreneurs in effective IP procurement practices, and in maximizing value from IP assets. He has been retained as a testifying witness in IP and licensing disputes by the U.S. Department of Justice, the U.S. Department of the Treasury, and by various private enterprises.
Brian has been acknowledged by IAM magazine as among its “IAM Strategy 300”, the world’s leading IP strategists, and among “The World's Leading Patent and Technology Licensing Lawyers.”
He earned B.S. and M.S. degrees from the Department of Chemistry, Rochester Institute of Technology, Rochester, NY; and Juris Doctor from Syracuse University, College of Law, Syracuse, NY (1986).
Brian has served his alma mater as president of the RIT Alumni Association 2005 – 2009; and now serves on the RIT Board of Trustees as a member of its Executive Committee, chair of its Student Life Committee, and vice-chair of its Committee on Trustees. In 2013, Brian was awarded RIT’s Outstanding Alumnus Award, and in 2005 he was awarded the Distinguished Alumnus Award by RIT’s College of Science.
Vice President, Global Head IP Affairs, Novartis
Corey Salsberg is the Vice President of Global Head IP Affairs in Novartis. He leads the Global IP Affairs function for Novartis, a multinational Fortune Global 200 healthcare company and world leader in innovative medicines and biosimilars.
Corey is a member of the Steering Committee and founder of the WIPO-World Economic Forum Inventors Assistance Program (IAP), an innovative international program aimed at providing pro bono IP services to under-resourced inventors and small businesses in developing countries.
Furthermore, he is one of architects of the Patent Information Initiative for Medicines (Pat-INFORMED), a voluntary global online database of patent information now co-sponsored and hosted by WIPO and the International Federation of Pharmaceutical Manufacturers (IFPMA).
Globally recognized thought leader, advocate, and speaker on IP, innovation and related topics. Recent engagements include testimony before the US Senate Judiciary, keynote address at the 7th Annual IBA World Life Sciences Conference, and many others.
Corey is a Stanford University of Law School graduate and Yale University undergraduate.
Executive Vice President, Goldwater Institute
Christina Sandefur is the Executive Vice President at the Goldwater Institute. She develops policies and litigates cases advancing healthcare freedom, free enterprise, private property rights, free speech, and taxpayer rights.
Christina is a co-drafter of the Right to Try initiative, now federal law, which protects terminally ill patients' right to try safe investigational treatments that have been prescribed by their physician but are not yet FDA-approved. She has won important victories for property rights in Arizona and works nationally to promote the Institute's Private Property Rights Protection Act, a state-level reform that requires government to pay owners when regulations destroy property rights and reduce property values.
Christina is the co-author of the book Cornerstone of Liberty: Private Property Rights in 21st Century America (2016). She is a frequent guest on national television and radio programs, has provided expert legal testimony to various legislative committees, and is a frequent speaker at conferences. She is the recipient of the 2018 Buckley Award in recognition of her leadership in the freedom movement, and she is an Advisory Board Member of the Network of enlightened Women. Christina serves on the board of the Phoenix Lawyers Chapter of the Federalist Society and is a member of the executive committee for the Federalist Society's Regulatory Transparency Project: FDA & Health.
Christina is a graduate of Michigan State University College of Law and Hillsdale College.
Senior Fellow, National Center for Policy Analysis
Senior Fellow at the National Center for Policy Analysis (NCPA) and author of Free To Choose Medicine: Better Drugs Sooner at Lower Cost
Adjunct Fellow, Competitive Enterprise Institute
Gregory Conko is an Adjunct Fellow at the Competitive Enterprise Institute and Vice President of Programs at DonorsTrust. His research at CEI focuses on health care, food and drug regulation, agriculture and agricultural trade, and nutrition and public health. He also has broad expertise in science and environmental policy and in administrative and regulatory law.
Since 2021, Conko has managed the grants and grantee programs at the donor-advised fund sponsor DonorsTrust, but he continues to research and write on policy matters for the Competitive Enterprise Institute. Before joining DonorsTrust, Conko was Deputy Director of the George Mason University Law & Economics Center, a Senior Fellow and later Executive Director of CEI.
Conko is the author or co-author of numerous books, studies, and articles, and Barron’s called his book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution, co-authored with Henry I. Miller, one of the 25 best books of 2004. His other writings have appeared in such journals as Nature Biotechnology, Transgenic Research, Health Matrix: Journal of Law & Medicine, and the Cumberland Law Review, and in such newspapers as the Financial Times, The Wall Street Journal, Los Angeles Times, and USA Today.
Conko is a member of the Federalist Society’s Regulatory Transparency Project Working Group on FDA & Health, a member of the American Council on Science and Health’s Board of Scientific and Policy Advisors. He received a JD degree magna cum laude from the George Mason University School of Law and a BA in political science and history from American University. He lives in Virginia with his wife and son.
Clinical Professor of Law, Dale E. Fowler School of Law, Chapman University
The Deterioration of Appropriate Remedies in Patent Disputes
Geoffrey A. Manne, Kristian Stout, Julian Morris, Dirk Auer
Note from the Editor: The Federalist Society takes no positions on particular legal and public...
Deep Dive Episode 118 – Can Patents and Bayh-Dole Fuel Innovation in the Time of COVID-19?
Lesley Millar-Nicholson, Adam Mossoff, Brian O'Shaughnessy, Corey Salsberg
Activists and politicians have responded to the worldwide COVID-19 pandemic by calling for the elimination...
Off-Label Promotion and Free Speech in Medicine
Christina Sandefur
Federal regulation strictly limits how pharmaceutical companies share information about the legal use of their...
Topics
Public Health Epidemics - Warning: This Litigation "Cure" Could Kill an Economy
A recent article in the Financial Times, Drug Industry faces ‘tidal wave’ of litigation over opioid...
Topics
Protecting Free Speech in Medicine
A year ago on this blog, I wrote that under federal law, pharmaceutical companies can...
The FDA treats innovators like outlaws - and it's taking a toll
In March, I posted about the pharmaceutical company Amarin’s legal battle with the federal Food...
Free To Choose Medicine
Bartley J. Madden, Gregory Conko
Note from the Editor: This article is about the Free To Choose Medicine concept....
Christopher v. SmithKline Beecham Corp. - Post-Decision SCOTUScast
Anthony (Tom) Caso
On June 18, 2012 the Supreme Court announced its decision in Christopher v. SmithKline Beecham Corp....
"Promoting the Progress" or Paying for Delay? Balancing Patent and Antitrust Law in the Age of Health Care Reform
Robert G. Pluta
In patent litigation valued between $1 million and $25 million, a patent owner should expect...
The Problem of Class Action Tolling in Mass Tort Personal Injury Litigation
Jessica D. Miller, Geoffrey Wyatt
A news story breaks. A drug manufacturer has announced the surprising results of a recent...